Colgate Palmolive Operating Expenses Growth & History (CL)
Colgate Palmolive's operating expenses was $8.95B for fiscal 2025.
View full Colgate Palmolive company overviewColgate Palmolive annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.95B | $1.05B | +13.33% |
| 2024 | 2024-12-31 | $7.89B | $551.0M | +7.50% |
| 2023 | 2023-12-31 | $7.34B | −$13.0M | −0.18% |
| 2022 | 2022-12-31 | $7.36B | $312.0M | +4.43% |
| 2021 | 2021-12-31 | $7.04B | $911.0M | +14.86% |
| 2020 | 2020-12-31 | $6.13B | $361.0M | +6.26% |
| 2019 | 2019-12-31 | $5.77B | $234.0M | +4.23% |
| 2018 | 2018-12-31 | $5.54B | −$36.0M | −0.65% |
| 2017 | 2017-12-31 | $5.57B | $405.0M | +7.84% |
| 2016 | 2016-12-31 | $5.17B | −$1.44B | −21.82% |
| 2015 | 2015-12-31 | $6.61B | $58.0M | +0.89% |
| 2014 | 2014-12-31 | $6.55B | −$93.0M | −1.40% |
| 2013 | 2013-12-31 | $6.64B | $602.0M | +9.96% |
| 2012 | 2012-12-31 | $6.04B | $294.0M | +5.11% |
| 2011 | 2011-12-31 | $5.75B | $34.0M | +0.59% |
| 2010 | 2010-12-31 | $5.71B | $322.0M | +5.97% |
| 2009 | 2009-12-31 | $5.39B | −$132.0M | −2.39% |
| 2008 | 2008-12-31 | $5.53B | $498.0M | +9.91% |
| 2007 | 2007-12-31 | $5.03B | — | — |
Colgate Palmolive quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.28B | $291.0M | +14.63% |
| Q1 2026 | 2026-03-31 | $2.26B | $351.0M | +18.37% |
| Q4 2025 | 2025-12-31 | $3.06B | $1.14B | +59.28% |
| Q3 2025 | 2025-09-30 | $1.99B | −$19.0M | −0.95% |
| Q2 2025 | 2025-06-30 | $1.99B | $15.0M | +0.76% |
| Q1 2025 | 2025-03-31 | $1.91B | −$81.0M | −4.07% |
| Q4 2024 | 2024-12-31 | $1.92B | $40.0M | +2.13% |
| Q3 2024 | 2024-09-30 | $2.01B | $161.0M | +8.71% |
| Q2 2024 | 2024-06-30 | $1.97B | $161.0M | +8.88% |
| Q1 2024 | 2024-03-31 | $1.99B | $189.0M | +10.48% |
| Q4 2023 | 2023-12-31 | $1.88B | −$494.0M | −20.83% |
| Q3 2023 | 2023-09-30 | $1.85B | $247.0M | +15.43% |
| Q2 2023 | 2023-06-30 | $1.81B | $143.0M | +8.56% |
| Q1 2023 | 2023-03-31 | $1.80B | $91.0M | +5.32% |
| Q4 2022 | 2022-12-31 | $2.37B | $178.0M | +8.11% |
| Q3 2022 | 2022-09-30 | $1.60B | −$55.0M | −3.32% |
| Q2 2022 | 2022-06-30 | $1.67B | $110.0M | +7.05% |
| Q1 2022 | 2022-03-31 | $1.71B | $79.0M | +4.84% |
| Q4 2021 | 2021-12-31 | $2.19B | $520.0M | +31.06% |
| Q3 2021 | 2021-09-30 | $1.66B | $134.0M | +8.80% |
| Q2 2021 | 2021-06-30 | $1.56B | $137.0M | +9.63% |
| Q1 2021 | 2021-03-31 | $1.63B | $120.0M | +7.93% |
| Q4 2020 | 2020-12-31 | $1.67B | $191.0M | +12.88% |
| Q3 2020 | 2020-09-30 | $1.52B | $62.0M | +4.25% |
| Q2 2020 | 2020-06-30 | $1.42B | $3.0M | +0.21% |
| Q1 2020 | 2020-03-31 | $1.51B | $105.0M | +7.46% |
| Q4 2019 | 2019-12-31 | $1.48B | $121.0M | +8.88% |
| Q3 2019 | 2019-09-30 | $1.46B | $65.0M | +4.66% |
| Q2 2019 | 2019-06-30 | $1.42B | $65.0M | +4.80% |
| Q1 2019 | 2019-03-31 | $1.41B | −$17.0M | −1.19% |
| Q4 2018 | 2018-12-31 | $1.36B | −$6.0M | −0.44% |
| Q3 2018 | 2018-09-30 | $1.40B | −$31.0M | −2.17% |
| Q2 2018 | 2018-06-30 | $1.35B | −$67.0M | −4.71% |
| Q1 2018 | 2018-03-31 | $1.43B | $68.0M | +5.01% |
| Q4 2017 | 2017-12-31 | $1.37B | $194.0M | +16.52% |
| Q3 2017 | 2017-09-30 | $1.43B | $173.0M | +13.81% |
| Q2 2017 | 2017-06-30 | $1.42B | $62.0M | +4.56% |
| Q1 2017 | 2017-03-31 | $1.36B | −$24.0M | −1.74% |
| Q4 2016 | 2016-12-31 | $1.17B | −$1.26B | −51.73% |
| Q3 2016 | 2016-09-30 | $1.25B | $42.0M | +3.47% |
| Q2 2016 | 2016-06-30 | $1.36B | −$75.0M | −5.23% |
| Q1 2016 | 2016-03-31 | $1.38B | −$151.0M | −9.86% |
| Q4 2015 | 2015-12-31 | $2.43B | $952.0M | +64.32% |
| Q3 2015 | 2015-09-30 | $1.21B | −$399.0M | −24.78% |
| Q2 2015 | 2015-06-30 | $1.44B | −$137.0M | −8.72% |
| Q1 2015 | 2015-03-31 | $1.53B | −$358.0M | −18.94% |
| Q4 2014 | 2014-12-31 | $1.48B | −$195.0M | −11.64% |
| Q3 2014 | 2014-09-30 | $1.61B | $41.0M | +2.61% |
| Q2 2014 | 2014-06-30 | $1.57B | −$56.0M | −3.44% |
| Q1 2014 | 2014-03-31 | $1.89B | $117.0M | +6.60% |
| Q4 2013 | 2013-12-31 | $1.68B | $112.0M | +7.17% |
| Q3 2013 | 2013-09-30 | $1.57B | $67.0M | +4.46% |
| Q2 2013 | 2013-06-30 | $1.63B | $149.0M | +10.07% |
| Q1 2013 | 2013-03-31 | $1.77B | $274.0M | +18.28% |
| Q4 2012 | 2012-12-31 | $1.56B | $93.0M | +6.33% |
| Q3 2012 | 2012-09-30 | $1.50B | $75.0M | +5.26% |
| Q2 2012 | 2012-06-30 | $1.48B | $43.0M | +2.99% |
| Q1 2012 | 2012-03-31 | $1.50B | $83.0M | +5.86% |
| Q4 2011 | 2011-12-31 | $1.47B | $25.0M | +1.73% |
| Q3 2011 | 2011-09-30 | $1.43B | $41.0M | +2.96% |
| Q2 2011 | 2011-06-30 | $1.44B | $142.0M | +10.97% |
| Q1 2011 | 2011-03-31 | $1.42B | −$174.0M | −10.94% |
| Q4 2010 | 2010-12-31 | $1.45B | $9.0M | +0.63% |
| Q3 2010 | 2010-09-30 | $1.39B | −$55.0M | −3.82% |
| Q2 2010 | 2010-06-30 | $1.29B | −$20.0M | −1.52% |
| Q1 2010 | 2010-03-31 | $1.59B | $388.0M | +32.28% |
| Q4 2009 | 2009-12-31 | $1.44B | — | — |
| Q3 2009 | 2009-09-30 | $1.44B | −$4.0M | −0.28% |
| Q2 2009 | 2009-06-30 | $1.31B | −$137.4M | −9.47% |
| Q1 2009 | 2009-03-31 | $1.20B | — | — |
| Q3 2008 | 2008-09-30 | $1.45B | — | — |
| Q2 2008 | 2008-06-30 | $1.45B | — | — |
Colgate Palmolive operating expenses trends
Over the last five fiscal years, Colgate Palmolive's operating expenses increased from $6.13B to $8.95B, a change of $2.81B. The latest reported quarter, Q2 2026, shows $2.28B.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Colgate Palmolive source filings ↗